Pharming Group (PHAR)
(Delayed Data from NSDQ)
$13.10 USD
-0.04 (-0.30%)
Updated Oct 31, 2025 02:21 PM ET
After-Market: $13.23 +0.13 (0.99%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth A Momentum A VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
PHAR 13.10 -0.04(-0.30%)
Will PHAR be a Portfolio Killer in November?
Zacks Investment Research is releasing its prediction for PHAR based on the 1-3 month trading system that more than doubles the S&P 500.

Zacks News for PHAR
CDTX Stock Soars 218% YTD on Positive Updates From Influenza Program
QURE Stock Skyrockets on Meeting Goals in Huntington's Disease Study
PHAR: What are Zacks experts saying now?
Zacks Private Portfolio Services
FDA Extends Review Period of Sanofi's Multiple Sclerosis Drug Filing
Zoetis Gains CVMP Backing for Portela, Eyes EU Approval in Cat OA Pain
RAPP Stock Soars 62% in a Week on Meeting Phase II Epilepsy Study Goal
Other News for PHAR
PHAR forms Narrow Range Bar on October 31
PHAR forms NR7 on October 30
PHAR falls 2.54% on October 29, leaving the technical picture intact
Technical picture remains unchanged for PHAR after it rises 3.23% on October 28
PHAR's price falls by 1.99% on October 27, though its technical setup remains stable.